← Back to Clinical Trials
Recruiting NCT07666334

NCT07666334 Subtransverse Process Interligamentary Plane Block Versus Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block for Analgesia in Pediatric Thoracotomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07666334
Status Recruiting
Phase
Sponsor Tanta University
Condition Subtransverse Process Interligamentary Plane Block
Study Type INTERVENTIONAL
Enrollment 75 participants
Start Date 2025-09-01
Primary Completion 2027-09-01

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Standard intravenous analgesiaSubtransverse process interligamentary plane blockRhomboid intercostal block (RIB) combined with sub-serratus plan block group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 75 participants in total. It began in 2025-09-01 with a primary completion date of 2027-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare ultrasound guided subtransverse process interligamentary plane block versus rhomboid intercostal block combined with sub-serratus plane block for postoperative analgesia in pediatric thoracotomy.

Eligibility Criteria

Inclusion Criteria: * Pediatric patients between 6 to 12 years. * Both sexes. * American Society of Anesthesiologists (ASA) Physical Status I - II. * Scheduled for thoracic surgery with thoracotomy incision under general anesthesia. Exclusion Criteria: * Parents who refused regional anesthesia. * Patients were presented with advanced kidney, cardiac or liver diseases. * Coagulation and bleeding disorders. * Patients presented with skin or soft tissue infection at the proposed site of needle Insertion. * Patients with cognitive impairment.

Contact & Investigator

Central Contact

Walaa A Elbialy, MSc

✉ walaaelbialy156@gmail.com

📞 00201095519412

Frequently Asked Questions

Who can join the NCT07666334 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Subtransverse Process Interligamentary Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07666334 currently recruiting?

Yes, NCT07666334 is actively recruiting participants. Contact the research team at walaaelbialy156@gmail.com for enrollment information.

Where is the NCT07666334 trial being conducted?

This trial is being conducted at Tanta, Egypt.

Who is sponsoring the NCT07666334 clinical trial?

NCT07666334 is sponsored by Tanta University. The trial plans to enroll 75 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology